Literature DB >> 273620

Bone marrow fibrosis in acute lymphoblastic leukaemia of childhood.

I M Hann, D I Evans, H B Marsden, P M Jones, M K Palmer.   

Abstract

A prospective study of bone marrow fibrosis was made in a group of 40 children with acute lymphoblastic leukaemia to see whether it affected the prognosis or course of the disease. Secondary myelofibrosis (SMF) was present at diagnosis in 57% of the cases. It was not statistically significantly related to the prognosis or course of the disease. Thus, although trephine biopsy occasionally provided useful information in different diagnosis and when aspiration was difficult, it provided little information of use for management.

Entities:  

Mesh：

Year:  1978        PMID： 273620      PMCID： PMC1145268          DOI： 10.1136/jcp.31.4.313

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  7 in total

1.  The reticulin content of bone marrow in haematological disorders.

Authors:  J BURSTON; J L PINNIGER
Journal:  Br J Haematol       Date:  1963-04       Impact factor: 6.998

2.  RETICULIN FIBROSIS AND BONE INFARCTION IN ACUTE LEUKEMIA. IMPLICATIONS FOR PROGNOSIS.

Authors:  D W KUNDEL; G BRECHER; G P BODEY; G M BRITTIN
Journal:  Blood       Date:  1964-04       Impact factor: 22.113

3.  The conflict of living matter with the mineral world: The pneumoconioses.

Authors:  A Policard
Journal:  J Clin Pathol       Date:  1962-09       Impact factor: 3.411

4.  Some speculations on the myeloproliferative syndromes.

Authors:  W DAMESHEK
Journal:  Blood       Date:  1951-04       Impact factor: 22.113

5.  [Myelofibrosis during hematologic diseases. Apropos of 402 cases].

Authors:  C Devred; J Diebold
Journal:  Sem Hop       Date:  1974-05-20

6.  Outpatient anaesthesia for a children's leukaemia clinic.

Authors:  D I Evans; P M Jones; P Morris; E A Shaw
Journal:  Lancet       Date:  1971-04-10       Impact factor: 79.321

7.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
  7 in total
  6 in total

1.  Bone marrow fibrosis in childhood acute lymphoblastic leukaemia.

Authors:  J P Wallis; M M Reid
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

Review 2.  Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications.

Authors:  Aziz Nazha; Joseph D Khoury; Raajit K Rampal; Naval Daver
Journal:  Oncologist       Date:  2015-08-24

3.  Bone marrow fibre content in acute myeloid leukaemia before and after treatment.

Authors:  A Islam; D Catovsky; J M Goldman; D A Galton
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

4.  Haemoglobin and prognosis in childhood acute lymphoblastic leukaemia.

Authors:  I M Hann; J H Scarffe; M K Palmer; D I Evans; P H Jones
Journal:  Arch Dis Child       Date:  1981-09       Impact factor: 3.791

5.  Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice.

Authors:  Inga Hofmann; Mitchell J Geer; Timo Vögtle; Andrew Crispin; Dean R Campagna; Alastair Barr; Monica L Calicchio; Silke Heising; Johanna P van Geffen; Marijke J E Kuijpers; Johan W M Heemskerk; Johannes A Eble; Klaus Schmitz-Abe; Esther A Obeng; Michael Douglas; Kathleen Freson; Corinne Pondarré; Rémi Favier; Gavin E Jarvis; Kyriacos Markianos; Ernest Turro; Willem H Ouwehand; Alexandra Mazharian; Mark D Fleming; Yotis A Senis
Journal:  Blood       Date:  2018-06-13       Impact factor: 22.113

6.  A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia.

Authors:  M K Palmer; I M Hann; P M Jones; D I Evans
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.